The Motley Fool
22 Nov 2026, 18:13 UTC · 1h ago
UiPath vs. Palantir Technologies: Which AI Automation Platform Makes a Better Stock Buy for 2027?
Impact · against what's priced in
The article provides no new catalysts for PLTR or PATH, as it primarily recaps financial metrics and market positions already absorbed by their respective valuations. The contrast between PLTR's high multiple and PATH's near-zero growth assumption remains the central, unchanged tension.
- PATH+0.00
Already priced in
- The price assumes
The delivered FY2026 business as it stands: $1.61bn revenue up 12.7%





